Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1175 of 3284 entries
View as:

Autoinjector Device Assessment Study

Phase: N/A Priority: Normal
NCT ID: NCT02349802 Org: User:
Start: 02/28/13 End: 12/31/13 Due: 12/31/14

The Study Will Evaluate the Effect of AZD9164 in Patients With Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT00939211 Org: User:
Start: 06/30/09 End: 11/30/09 Due: 11/30/10

A Study to Assess the Lung Exposure Bioequivalence of Budesonide, Glycopyrronium, & Formoterol (BGF) Metered Dose Inhaler (MDI) Hydrofluoroolefin (HFO) With a Spacer (Treatment B), BGF MDI Hydrofluoroalkane (HFA) With a Spacer (Treatment A), as Well as BGF MDI HFO Without a Spacer (Treatment C)

Phase: N/A Priority: Normal
NCT ID: NCT06340581 Org: User:
Start: 10/17/24 End: 02/27/25 Due: 02/27/26

NIS-observe Treatment Efficacy in Maintaining Symptoms Control in Moderate/Severe Asthma With Symbicort SMART

Phase: N/A Priority: Normal
NCT ID: NCT00785733 Org: User:
Start: 11/30/08 End: 10/31/09 Due: 10/31/10

A Diabetes Study to Treat A Population Previously Not at Target

Phase: N/A Priority: Normal
NCT ID: NCT00747149 Org: User:
Start: 05/31/08 End: 08/31/09 Due: 08/31/10

Safety, Tolerability, Pharmacokinetics and Efficacy of AZD1208 in Acute Myelogenous Leukemia (AML) Patients

Phase: N/A Priority: Normal
NCT ID: NCT01489722 Org: User:
Start: 02/29/12 End: 05/31/14 Due: 05/31/15

An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants

Phase: N/A Priority: Normal
NCT ID: NCT05835310 Org: User:
Start: 03/14/24 End: 03/12/30 Due: 03/12/31

A Study to Investigate Changes in Symptoms in Adult Participants With Chronic Rhinosinusitis With Nasal Polyposis Initiating Treatment With Tezepelumab

Phase: N/A Priority: Normal
NCT ID: NCT06706817 Org: User:
Start: 12/03/24 End: 01/29/27 Due: 01/29/28

An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)

Phase: N/A Priority: Normal
NCT ID: NCT05952557 Org: User:
Start: 10/05/23 End: 05/06/37 Due: 05/06/38

Ravulizumab Treatment Outcomes in Patients With Generalized Myasthenia Gravis

Phase: N/A Priority: Normal
NCT ID: NCT06909253 Org: User:
Start: 05/15/25 End: 12/31/29 Due: 12/31/30

A Global Study of Volrustomig (MEDI5752) Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy for Participants With Metastatic Non-small Cell Lung Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT05984277 Org: User:
Start: 10/24/23 End: 05/16/29 Due: 05/16/30

Non-interventional Study to Evaluate the Change in Symptoms Scores and Treatment Response After 4 Weeks of Proton-Pump Inhibitors (PPI) Treatment

Phase: N/A Priority: Normal
NCT ID: NCT01103804 Org: User:
Start: 03/31/10 End: 09/30/10 Due: 09/30/11

The PK and PD of Dapagliflozin Therapy in Combination With Insulin in Japanese Subjects With T1DM

Phase: N/A Priority: Normal
NCT ID: NCT02582840 Org: User:
Start: 10/31/15 End: 06/30/16 Due: 06/30/17

THALES - Acute STroke or Transient IscHaemic Attack Treated With TicAgreLor and ASA for PrEvention of Stroke and Death

Phase: N/A Priority: Normal
NCT ID: NCT03354429 Org: User:
Start: 01/22/18 End: 12/13/19 Due: 12/13/20

Clinical Outcome of Corticosteroids in the Treatment of COPD Exacerbations in China

Phase: N/A Priority: Normal
NCT ID: NCT03633838 Org: User:
Start: 02/28/17 End: 02/28/17 Due: 02/28/18

A Study on Intima Media Thickness (IMT) in Middle-aged Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00784264 Org: User:
Start: 10/31/08 End: 06/30/09 Due: 06/30/10

A Study of T-DXd for the Treatment of Solid Tumors Harboring HER2 Activating Mutations

Phase: N/A Priority: Normal
NCT ID: NCT04639219 Org: User:
Start: 12/30/20 End: 07/14/26 Due: 07/14/27

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

Phase: N/A Priority: Normal
NCT ID: NCT06878261 Org: User:
Start: 03/25/25 End: 06/05/29 Due: 06/05/30

Safety and Efficacy Study to Determine Anti-Asthmatic Effect of Esomeprazole Magnesium; Nexium Reflux Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00317044 Org: User:
Start: 04/30/06 End: 07/31/08 Due: 07/31/09

Antihypertensive Efficacy and Safety of Candesartan/HCT 32/25 mg in Comparison With Individual Components and Placebo

Phase: N/A Priority: Normal
NCT ID: NCT00434967 Org: User:
Start: 01/31/07 End: 01/31/08 Due: 01/31/09

A Study of MEDI7352 in Painful Osteoarthritis of the Knee

Phase: N/A Priority: Normal
NCT ID: NCT02508155 Org: User:
Start: 11/17/15 End: 12/23/20 Due: 12/23/21

COmpliance and Efficacy in Mono and Combination Tablet Study ATacand/Atacand Plus

Phase: N/A Priority: Normal
NCT ID: NCT00526279 Org: User:
Start: 06/30/07 End: 08/31/08 Due: 08/31/09

Evaluation of Onset of Effect in Patients With Severe Chronic Obstructive Pulmonary Disease (COPD) Treated With Symbicort® Compared to Seretide®

Phase: N/A Priority: Normal
NCT ID: NCT00542880 Org: User:
Start: 09/30/07 End: 08/31/08 Due: 08/31/09

Epidemiological Study to Evaluate Adherence to Treatment in Bipolar Disorder: Adherence Study

Phase: N/A Priority: Normal
NCT ID: NCT00927420 Org: User:
Start: 07/31/09 End: 10/31/09 Due: 10/31/10

Efficacy and Safety of Roflumilast in Japanese Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (APTA-2217-06)

Phase: N/A Priority: Normal
NCT ID: NCT00242294 Org: User:
Start: 11/30/04 End: 03/31/07 Due: 03/31/08